Luye Pharma Group Ltd.
76
6
9
47
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 76 trials
100.0%
+13.4% vs industry average
17%
13 trials in Phase 3/4
0%
0 of 47 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (76)
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Role: lead
A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects
Role: lead
Mass Balance Study of [14C] LPM3770164 in Healthy Participants
Role: lead
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
Role: lead
LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
Role: lead
To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
Role: lead
A Food Effect Study of LY03020 in Healthy Subjects
Role: lead
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Role: lead
Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)
Role: lead
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
Role: lead
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
Role: lead
Effect of Food and Age on the Pharmacokinetics of LY03017
Role: lead
Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Role: lead
Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets
Role: lead
Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
Role: lead
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
Role: lead
Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery
Role: lead
Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
Role: lead
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
Role: lead
Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
Role: collaborator